Haemonetics' Q2 Earnings and Revenues Top, Stock Up, Margins Expand

Haemonetics Corporation (HAE) delivered adjusted earnings per share (EPS) of $1.12 in the second quarter of fiscal 2025, up 13.1% year over year. The bottom line surpassed the Zacks Consensus Estimate by 2.8%.On a GAAP basis, the EPS was 66 cents compared with 48 cents in the prior-year quarter.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Following the earnings announcement on Nov. 7, shares of HAE increased 1% in Friday’s session, finishing at$ 87.42.HAE’s Q2 Total RevenuesRevenue ...